BlueRock Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- BlueRock Therapeutics's estimated annual revenue is currently $85.7M per year.
- BlueRock Therapeutics's estimated revenue per employee is $155,000
Employee Data
- BlueRock Therapeutics has 553 Employees.
- BlueRock Therapeutics grew their employee count by 33% last year.
BlueRock Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP, General Counsel | Reveal Email/Phone |
2 | VP, Assay Development | Reveal Email/Phone |
3 | Head Supply Chain and CMC Strategy | Reveal Email/Phone |
4 | SVP, Head Finance | Reveal Email/Phone |
5 | Director FP&A | Reveal Email/Phone |
6 | Director FP&A | Reveal Email/Phone |
7 | Director Facilities and EHS | Reveal Email/Phone |
8 | Chief Technology Officer | Reveal Email/Phone |
9 | Associate Director, Information Technology | Reveal Email/Phone |
10 | Associate Director, CNS Cell Biology | Reveal Email/Phone |
BlueRock Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is BlueRock Therapeutics?
BlueRock Therapeutics is a next-generation regenerative medicine company focused on breakthrough stem cell technology treatments of cardiovascular and neurodegenerative diseases. BlueRock Therapeutics has launched with the backing of a combined $225 million investment by Bayer and biotechnology investment firm Versant Ventures. BlueRock’s initial programs will focus on induced pluripotent stem cell (iPSC)-derived therapeutics to expand their technology pipeline.
keywords:N/A
N/A
Total Funding
553
Number of Employees
$85.7M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BlueRock Therapeutics News
In 2019, Bayer fully acquired BlueRock Therapeutics, a cell therapy developer it had formed three years earlier as a joint venture with...
Some of Leaps' bets so far have been in cell therapy, including BlueRock Therapeutics, which Bayer eventually fully acquired for up to $600 million in 2019.
... innovation for cell and gene therapies, says Bayer's Jens Vogel. ... when it bought out cell therapy developer BlueRock Therapeutics.
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $105.8M | 564 | 8% | N/A |
#2 | $180.9M | 572 | 7% | N/A |
#3 | $104.2M | 575 | 6% | N/A |
#4 | $236.7M | 590 | N/A | N/A |
#5 | $53.7M | 591 | 6% | $484M |